SK13097A3 - Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use - Google Patents

Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use Download PDF

Info

Publication number
SK13097A3
SK13097A3 SK130-97A SK13097A SK13097A3 SK 13097 A3 SK13097 A3 SK 13097A3 SK 13097 A SK13097 A SK 13097A SK 13097 A3 SK13097 A3 SK 13097A3
Authority
SK
Slovakia
Prior art keywords
optically active
ester
pharmaceutically acceptable
active compound
amide
Prior art date
Application number
SK130-97A
Other languages
English (en)
Slovak (sk)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of SK13097A3 publication Critical patent/SK13097A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
SK130-97A 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use SK13097A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (fr) 1995-06-01 1996-05-28 Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaire

Publications (1)

Publication Number Publication Date
SK13097A3 true SK13097A3 (en) 1997-08-06

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
SK130-97A SK13097A3 (en) 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use

Country Status (31)

Country Link
EP (1) EP0796247A1 (fr)
JP (1) JP2885941B2 (fr)
KR (1) KR100245957B1 (fr)
AT (1) AT406675B (fr)
AU (1) AU710105B2 (fr)
BE (1) BE1009520A5 (fr)
BR (1) BR9606409A (fr)
CA (1) CA2194397A1 (fr)
CH (1) CH691808A5 (fr)
CZ (1) CZ26997A3 (fr)
DE (1) DE19680509T1 (fr)
DK (1) DK10697A (fr)
ES (1) ES2137886B1 (fr)
FI (1) FI970393A (fr)
GB (1) GB2304340B (fr)
GR (1) GR1002702B (fr)
HU (1) HUP9700274A3 (fr)
IE (1) IE960405A1 (fr)
IL (1) IL118477A0 (fr)
IT (1) IT1290839B1 (fr)
LU (1) LU90008B1 (fr)
MC (1) MC2418A1 (fr)
MX (1) MX9700379A (fr)
NL (1) NL1003243C2 (fr)
NO (1) NO307460B1 (fr)
NZ (1) NZ308597A (fr)
PL (1) PL318440A1 (fr)
SE (1) SE510812C2 (fr)
SK (1) SK13097A3 (fr)
TR (1) TR199700020T1 (fr)
WO (1) WO1996038416A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (fr) * 1982-07-28 1985-03-27 The Upjohn Company Hétéroalkysylalkanoles 3-pyridinyliques, leurs acides alkanoiques et leurs esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds
PT825184E (pt) * 1993-03-29 2001-11-30 Astrazeneca Ab Derivados heterociclicos como inibidores de agregacao de plaquetas

Also Published As

Publication number Publication date
NO307460B1 (no) 2000-04-10
AU710105B2 (en) 1999-09-16
SE9700203D0 (sv) 1997-01-24
IT1290839B1 (it) 1998-12-14
JPH09512836A (ja) 1997-12-22
PL318440A1 (en) 1997-06-09
CA2194397A1 (fr) 1996-12-05
NO970437L (no) 1997-02-20
GB2304340B (en) 1998-07-29
NO970437D0 (no) 1997-01-31
AT406675B (de) 2000-07-25
NZ308597A (en) 1998-11-25
ES2137886A1 (es) 1999-12-16
JP2885941B2 (ja) 1999-04-26
ITMI961113A0 (it) 1996-05-31
EP0796247A1 (fr) 1997-09-24
GB2304340A (en) 1997-03-19
HUP9700274A3 (en) 2000-02-28
ES2137886B1 (es) 2000-08-16
ATA900596A (de) 1999-12-15
HU9700274D0 (en) 1997-04-28
NL1003243C2 (nl) 1996-12-04
GB9627127D0 (en) 1997-02-19
FI970393A0 (fi) 1997-01-30
GR1002702B (el) 1997-05-22
ITMI961113A1 (it) 1997-12-01
TR199700020T1 (tr) 1997-04-22
DK10697A (da) 1997-04-01
BR9606409A (pt) 1997-09-30
SE510812C2 (sv) 1999-06-28
LU90008B1 (fr) 1997-04-16
SE9700203L (sv) 1997-01-24
IL118477A0 (en) 1996-09-12
WO1996038416A1 (fr) 1996-12-05
FI970393A (fi) 1997-01-30
AU5827296A (en) 1996-12-18
CH691808A5 (de) 2001-10-31
CZ26997A3 (en) 1997-08-13
KR100245957B1 (ko) 2000-04-01
IE960405A1 (en) 1996-12-11
HUP9700274A2 (hu) 1999-06-28
BE1009520A5 (fr) 1997-04-01
DE19680509T1 (de) 1997-12-04
MX9700379A (es) 1997-04-30
KR970704689A (ko) 1997-09-06
MC2418A1 (fr) 1997-05-23

Similar Documents

Publication Publication Date Title
DE69912379T2 (de) Antithrombosemittel
US6333337B1 (en) Potassium channel inhibitors
SK120895A3 (en) Pyridine derivatives, process for preparing the same and intermediate products in this process and pharmaceutical compositions containing them
JP2002528495A (ja) ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法
KR101373911B1 (ko) Bcl 단백질과 결합 파트너의 상호작용을 억제하기 위한화합물 및 방법
US4873253A (en) Phenylalanine derivative and proteinase inhibitor
CZ297544B6 (cs) Substituované N-[(aminoiminomethyl)-fenyl]propylamidy nebo N-[(aminomethyl)fenyl]propylamidy
SK16512000A3 (sk) Heterocyklické deriváty inhibujúce faktor xa, farmaceutická kompozícia s ich obsahom a ich použitie
SK6992000A3 (en) Compounds useful as competitive inhibitors of trypsin-like serine proteases, method for the preparation thereof, pharmaceutical compositions containing same and their use
EP1124824B1 (fr) Derives de chromenone et de chromanone utilises comme inhibiteurs d'integrine
AU2009248231A1 (en) Novel N-(2-amino-phenyl)-acrylamides
JPH09502448A (ja) 心臓血管系に活性な2−アミノ−1,2,3,4−テトラヒドロナフタレン誘導体
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
AU2004276128A1 (en) Amide-type carboxamide derivatives
US4963587A (en) Glycine derivative and pharmaceutical preparation thereof
SK13097A3 (en) Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use
JPH0717942A (ja) 化合物
EP0718307A2 (fr) Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique
CN102924567B (zh) 一类肽化合物、其制备方法及用途
US5672712A (en) Thiazoline derivatives
NZ336003A (en) Use of compositions containing diarylalkane derivatives for treating or preventing pancreatitis
MXPA05006032A (es) Derivado cristalino de 2-(5 -clorotien -2-il) -n -{(3s) -1-[(1s) -1-metil -2-morfolin -4-il -2- oxoetil] -2- oxopirrolidin- 3-il} etenosulfonamida.
JPH02311479A (ja) キノリン誘導体
FR2734818A1 (fr) Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant